Welcome

The Tara Miller Melanoma Center at the Abramson Cancer Center of the University of Pennsylvania is a comprehensive center that unites research, clinical care, education, and outreach programs to improve the lives of patients with melanoma.  Despite tremendous advances in melanoma therapy, current therapies do not cure every patient. Many patients are still suffering and dying from melanoma. The Tara Miller Melanoma Center is dedicated to overcoming this challenge. 

We are committed to providing exceptional care to all of our patients with melanoma and other types of skin cancers. Using a multidisciplinary approach, we deliver personalized care, integrating and connecting with providers from Dermatology, Medical Oncology, Surgical Oncology, Radiation Oncology, and Pathology. We also collaborate with basic, translational, and population scientists who study new ways to prevent, diagnose, and treat melanoma. The Center supports innovative research to truly change the trajectory of the disease for an individual patient. The Tara Miller Melanoma Center is a place where patients and their families can turn to for education and find up to date information regarding the best treatments for melanoma. 

The Tara Miller Melanoma Center was established in 2019 with generous support from Debbie and George Miller in honor of their daughter, Tara Miller. As Dr. Bob Vonderheide, the Director of the Abramson Cancer Center said, “The number of people who were moved by Tara’s courage and her character is second only the number of lives that will be forever changed by her legacy”.  

 

Make the Best of It Bash banner

 

12th Annual Make The Best Of It Bash

Friday, June 27, 2025

7:00 PM - 10:00 PM
Golden Nugget, Atlantic City
Hotel, Casino & Marina

Enjoy an evening of Cocktails & Dinner, Amazing Silent Auction & After Party. Past highlights include dinner with Philadelphia Eagles, Five Star Four Seasons villa for a week, jewelry, experiences and more.

CLICK HERE FOR EVENT TICKETS, SPONSORSHIP, OR DONATE

Click Here To Book Your Discounted Hotel Stay
Group Code: ATMMF25 

Dr. Amaravadi named Tara Miller Professor of Melanoma Research and Patient Care

picture of TMMC group celebrating Dr. Amaravadi's professorship       picture of Dr. Amaravadi

Dr. Ravi Amaravadi has been named the inaugural chairholder of the Tara Miller Professor of Melanoma Research and Patient Care, established by Debbie and George Miller to honor their late daughter, Tara.

Dr. Amaravadi is a Professor of Medicine, Scientific Director of the Tara Miller Melanoma Center, Associate Director of Translational Research for the Abramson Cancer Center, and is co-director of the Wistar-Penn SPORE Skin Cancer grant, a multi-million-dollar grant that supports translational research in melanoma.


Dr. Joanna Walker Identifies Skin Cancer During On-Air Sun Safety Segment

Mike Jerrick, co-host of Good Day Philadelphia, brought dermatologist, Dr. Joanna Walker, on air before the pair discovered a likely-cancerous spot on the hosts' elbow

While on set of Good Day Philadelphia on FOX29 Philadelphia News to discuss skin cancer awareness, Dr. Joanna Walker identifies a basal cell carcinoma on co-host Mike Jerrick's arm. Basal cell carcinoma is the most common type of cancer and very treatable when caught early.

Dr. Walker is an Assistant Professor of Clinical Dermatology, Director of Rare and Advanced Skin Cancer Clinic, and member of the Tara Miller Melanoma Center.

To read the full article: Daily Mail | Daily Express | The Sun | Mediaite | The Independent 


 patient conference banner

Overview

The 22nd Annual Focus on Melanoma conference is designed to address the personal and medical issues of those whose lives have been affected by melanoma. Gain knowledge and take action by getting important information from our expert speakers. Receive hope and support by networking with others. 

CLICK HERE to view the video recording.

If you attended, thank you for joining us.
CLICK HERE to complete the event survey.
If you did not attend, we want to hear from you too!
CLICK HERE to complete a short survey.

TIL Therapy Now Available!

TIL therapy is a type of immunotherapy that uses your body's own T cells (lymphocytes) to find and eliminate cancer cells. This new treatment is now available at Penn for eligible patients with advanced/metastatic melanoma that has not responded to targeted therapies or other immunotherapies. To schedule an appointment with our Penn melanoma care team for evaluation, please contact: 215-615-5858.